-
- Posted Thursday November 14, 2019
TGen-USC researchers link sisters’ paralysis to an ‘extremely rare’ genetic variant
Diagnosis by TGen’s Center for Rare Childhood Disorders gives solace to parents who searched a quarter-century for answers
PHOENIX, Ariz. — Nov. 14, 2019 — Following a nearly 25-year search across three continents, parents of a pair of sisters — who as children slowly became paralyzed from the waist down — finally have a diagnosis, according to researchers at University of Southern California (USC) and Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
These findings were reported today in the scientific journal Human Mutation.
Thanks to a chance viewing on French TV of a story about another physically disabled child who regained her mobility after being diagnosed at TGen’s Center for Rare Childhood Disorders (the Center), the parents of the two sisters contacted TGen, hoping to end their decades-long diagnostic odyssey.
“The girls’ parents were one of the many who emailed me after seeing the TGen interview on French TV,” recalled Dr. Matt Huentelman, Professor of TGen’s Neurogenomics Division, Scientific Director of the Center, and one of the paper’s authors. “I can still remember the pain, desperation and hope expressed in those emails.”
Using multiple analyses of the sisters’ and family members’ genomic sequencing, TGen and USC investigators found that an “extremely rare” genetic variant in the gene AP4S1 was the likely culprit that left the girls, by age 5, paralyzed from the waist down.
Twenty years later, following a physical exam at ages 24 and 25, their physician noted that the sisters were “pleasant and happy,” but remained shy, unable to talk, and still in need of their motorized wheelchairs. The sisters have required multiple foot surgeries associated with their condition, have no bladder or bowel control, and require daily assistance with bathing, feeding and dressing.
“This family literally went all over the world in search for a diagnosis,” said Newell Belnap, Clinical Research Coordinator at the Center, and one of the study’s authors.
Quoting from one of the mother’s emails: “I took them everywhere, to any doctor, any neurologist who could diagnose the disease.”
Originally from the Democratic Republic of the Congo, in east Africa, the family eventually traveled to Paris, France; Geneva, Switzerland; and elsewhere in Europe before arriving in the U.S. in 1999, all the time in search of a doctor who could provide a diagnosis.
In 2014, the parents saw a story featured on France 2, the French national television channel, about a young girl who after being diagnosed and treated at the Center, was able to discard her wheelchair, stand and walk — and even dance.
Eventually, after finding their way to the Center, the sisters, other siblings and their parents had their DNA sequenced. Initially, TGen and USC researchers could not find a cause for their disabilities.
“Given the lack of evidence for a causative variant, we performed RNA sequencing and compared the resulting gene expression profiles to a broader group of more than 150 other pediatric patients enrolled under our research protocol,” said Dr. Vinodh Narayanan, the Center’s Medical Director and one of the study’s authors.
Using these precision medicine techniques, the team was able to pinpoint the “extremely rare” variant — one that had been skipped over by researchers in the past — in the AP4S1 gene.
“This in-depth case study demonstrates the utility of whole-blood mRNAseq — even when genes are expressed at very low levels — in identifying a variant not previously considered likely pathogenic,” said Dr. David Craig, a former TGen researcher who now is Co-Director of the USC Institute of Translational Genomics at the USC Keck School of Medicine. Dr. Craig is the senior author of this study.
Key research and analysis for this study were provided by: Carmel McCullough, a Research Assistant II at USC’s Keck School of Medicine, and a former member of Helios Scholars at TGen; and by Dr. Szabolcs Szelinger, a Research Assistant Professor in TGen’s Neurogenomics Division. McCullough and Dr. Szelinger are co-lead authors of this study.
“Given that DNA and RNA can be obtained at the same time — and integrative analytical frameworks, such as ours, can gather additional evidence — these approaches have the promise to improve clinical diagnosis, especially in some diseases where most patients remain undiagnosed even after genome or exome sequencing,” Dr. Szelinger said.
Funding for this study — Utilizing RNA and outlier analysis to identify an intronic splice‐altering variant in AP4S1 in a sibling pair with progressive spastic paraplegia — was provided by USC, and by private anonymous donations to TGen’s Center for Rare Childhood Disorders.
# # #
About TGen, an affiliate of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life-changing results. TGen is affiliated with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases: www.cityofhope.org. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org. Follow TGen on Facebook, LinkedIn and Twitter @TGen.
Media Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
About the Keck School of Medicine of USC
Founded in 1885, the Keck School of Medicine of USC is among the nation’s leaders in innovative patient care, scientific discovery, education and community service. The school has more than 1,850 full-time faculty members and voluntary faculty numbering more than 2,400 physicians. These faculty direct the education of approximately 800 medical students and 1,000 students pursuing graduate and postgraduate degrees. The school trains more than 900 resident physicians in more than 50 specialty or subspecialty programs and is the largest educator of physicians practicing in Southern California. Keck School faculty also lead research and education within 26 research-oriented basic science and clinical departments, and 17 research institutes across USC’s Health Sciences Campus. The Keck School was ranked No. 30 in research in the 2020 U.S. News & World Report “Best Graduate Schools” rankings.
For more information, visit keck.usc.edu.
Media Contact:
Leigh Hopper
Media Relations Specialist
University of Southern California
Cell: 310-308-0405
